Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
BWX Technologies (BWXT): A -5.5% Pullback Amid Record Backlog and Raised Guidance

BWX Technologies (BWXT): A -5.5% Pullback Amid Record Backlog and Raised Guidance

Key Takeaways

  • BWXT shares traded near $130.88 in late October 2026, down roughly 5.5% from about $138.47 a month earlier, keeping the 30-day move below the 10% threshold.
  • The pullback contrasts with a strengthening fundamental picture: second-quarter 2026 revenue rose 18% year over year to $901.6 million, with adjusted earnings of $1.07 per share.
  • Management raised its full-year 2026 outlook to about $3.80 billion in revenue, $4.70–$4.80 in adjusted EPS, and $662–$672 million in adjusted EBITDA.
  • BWXT ended the second quarter with a roughly $8.4 billion backlog, up about 40% year over year, and a trailing 12-month book-to-bill ratio of 1.7x.
  • Commercial Operations revenue surged roughly 72% year over year in the quarter, reflecting nuclear components, field services, fuel handling, and the Kinectrics contribution.
  • Get additional detail on the company's Price Targets, Earnings, and Forecast across dedicated pages.
  • Explore Trending AI Robots to see how AI-driven trading strategies are tracking BWXT and thousands of other tickers.

Where BWXT Stands in the Current Market

BWX Technologies shares have moved in a choppy, lower range through the fall of 2026. The stock eased from the mid-$140s to roughly $130 in a matter of weeks, reflecting profit-taking and broader valuation pressure across the nuclear and defense complex rather than any weakening in operating results. This recent softness stands in contrast to the longer-term strength of the nuclear theme, where demand tied to naval propulsion, grid decarbonization, and electricity-intensive data centers has kept investor attention elevated.

Sentiment on the name remains mixed. Several analysts reiterated constructive ratings while trimming price targets, and the consensus view still leans positive, though near-term execution and a fourth-quarter-heavy earnings profile have kept a lid on enthusiasm. The stock's move of less than 10% over the trailing 30 days leaves it within a normal trading range for a large-cap industrial. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

BWX Technologies Business Overview and Competitive Position

BWX Technologies, Inc. designs and manufactures nuclear components, fuel, and specialized services across two segments: Government Operations and Commercial Operations. In Government Operations, BWXT is the sole manufacturer of nuclear reactors and fuel for the U.S. Navy's submarine and aircraft-carrier fleets, while also handling national security materials, uranium processing, and advanced and microreactor programs. In Commercial Operations, the company supplies steam generators, reactor components, fuel, and field services for commercial nuclear plants, including CANDU reactors, and serves the nuclear medicine market.

The company's competitive moat rests on unique regulatory licenses, security clearances, and highly specialized manufacturing infrastructure that are difficult to replicate. BWXT describes itself as the only large commercial nuclear equipment manufacturer in North America. That positioning, combined with a multi-year backlog concentrated in long-cycle naval propulsion work, gives the company significant revenue visibility and pricing power relative to many industrial peers. Investors follow the stock closely as a bellwether for both U.S. defense spending and the revival of commercial nuclear power.

Recent Developments Driving BWXT

The most consequential recent development was BWXT's decision to raise its 2026 financial guidance following second-quarter results. Revenue of $901.6 million rose 18% year over year, while Commercial Operations revenue climbed roughly 72%, including about 33% organic growth. The company also lifted its full-year free cash flow outlook to $345–$360 million.

Portfolio activity reshaped the business during the period. BWXT completed its acquisition of Precision Components Group in July, adding commercial nuclear manufacturing capability, and agreed to sell just over 80% of its medical business and Kinectrics stable-isotope enrichment operations to Nordic Capital in a transaction valued at up to $800 million, allowing management to focus on nuclear national security and commercial power.

Analyst activity has been mixed. Northland Securities and Jefferies issued Buy ratings in early October, while Truist Financial and Maxim Group maintained Hold ratings, and Wells Fargo reiterated a Hold with a $170 price target. Bank of America trimmed its target from $250 to $210. These revisions, alongside broader sector rotation, contributed to the recent softness in the share price even as the underlying backlog and demand signals remained strong.

2026 Outlook and What Investors Should Watch

BWXT's forward story centers on converting a record backlog into earnings. Management has pointed to the nuclear industry's "multi-decade super cycle," supported by naval propulsion, national security programs, and commercial reactor demand. The company expects its next quarterly earnings release around early November 2026, and consensus estimates point to revenue of roughly $992 million and EPS near $1.19, which will be closely watched for signs that execution remains on track.

Key factors to monitor include the pace of new-build nuclear equipment orders, capacity expansion decisions, and the margin trajectory in Commercial Operations, where management lowered its 2026 adjusted EBITDA margin guidance to about 13% to fund growth investments. The concentration of second-half earnings in the fourth quarter also adds execution risk. On the government side, defense budget priorities and contract award timing remain important swing factors. Broader nuclear peers such as GE Vernova and Huntington Ingalls Industries underscore how demand for nuclear equipment and naval shipbuilding continues to shape the sector's outlook. From what I see, this is important because the backlog conversion will test execution in the quarters ahead.

AI Tools for Monitoring Nuclear Names

I have found Tickeron's AI Trading Bots helpful when tracking automated strategies across defense and nuclear stocks like BWXT. The platform surfaces top-performing bots that monitor thousands of tickers, allowing a quick comparison of different algorithmic approaches without relying on a single model. This gives a useful window into how quantitative systems are positioning in real time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BWXT

BWXT's Indicator enters downward trend

The Aroon Indicator for BWXT entered a downward trend on November 16, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 140 similar instances where the Aroon Indicator formed such a pattern. In 100 of the 140 cases the stock moved lower. This puts the odds of a downward move at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWXT as a result. In 49 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.

The Moving Average Convergence Divergence Histogram (MACD) for BWXT turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BWXT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +11.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in 226 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

BWXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWXT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. BWXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.206) is normal, around the industry mean (5.050). P/E Ratio (30.884) is within average values for comparable stocks, (17.247). BWXT's Projected Growth (PEG Ratio) (27.780) is very high in comparison to the industry average of (3.110). Dividend Yield (0.009) settles around the average of (0.055) among similar stocks. P/S Ratio (3.811) is also within normal values, averaging (18.367).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -16%. For the same Industry, the average monthly price growth was -17%, and the average quarterly price growth was -35%. POWW experienced the highest price growth at 13%, while VWAV experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 41%. For the same stocks of the Industry, the average monthly volume growth was 16% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 53
Price Growth Rating: 65
SMR Rating: 78
Profit Risk Rating: 79
Seasonality Score: -14 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of components and services to nuclear power industry

Industry AerospaceDefense

Industry
Aerospace And Defense
Address
800 Main Street
Phone
+1 980 365-4300
Employees
10400
Web
https://www.bwxt.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.